Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THC 2% oil for chronic neuropathic pain
NL-OMON58984Phase 2Recruiting
- Sponsor
- Centre for Human Drug Research
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of dronabinol in chronic neuropathic pain, sponsored by Centre for Human Drug Research. Primary endpoints: Pain severity Numeric Rating Scale weekly average and Experience sampling method pain Numeric Rating Scale. Started Feb 2024; status: recruiting.
02
Drugs
dronabinol
03
Conditions
chronic neuropathic pain
Beyond the preview
Go deeper on NL-OMON58984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58984.